Literature DB >> 6704065

Comparison of the immunogenicity of Newcastle disease virus strains V4, Hitchner B1 and La Sota in chickens. 2. Tests in chickens with maternal antibody to the virus.

H A Westbury, G Parsons, W H Allan.   

Abstract

The immunogenicity of three Newcastle disease virus (NDV) strains--V4, Hitchner B1 and La Sota, was assessed in chickens that had varying levels of maternal antibody to the virus. Chickens were immunised at different ages by the eye drop and aerosol methods. The immune response of chickens to similar doses of the strains was affected by the presence of maternal antibody. Both the level of maternal antibody and the strain of virus used affected the result. Strain La Sota was least affected as it took higher levels of maternal antibody to depress response to it than were required to have a similar effect on Hitchner B1 and V4. Strain V4 was the strain most affected by circulating maternal antibody. The results demonstrated that strain V4 was less immunogenic than Hitchner B1 and La Sota when used in chickens with maternal antibody to NDV.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704065     DOI: 10.1111/j.1751-0813.1984.tb07121.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  3 in total

1.  Observations on the use of Komarov strain of Newcastle disease vaccine in the Sudan.

Authors:  M A Gaffar Elamin; A I Khalafalla; S M Ahmed
Journal:  Trop Anim Health Prod       Date:  1993-08       Impact factor: 1.559

2.  In-ovo Newcastle disease virus vaccine strain TS09-C protects commercial chickens against Newcastle disease in the presence of maternally derived antibodies.

Authors:  Sanling Fan; Yulun Wu; Hongling Wang; Yu Shang; Qingping Luo; Tengfei Zhang; Rongrong Zhang; Wenting Zhang; Ling Luo; Huabin Shao; Guoyuan Wen
Journal:  Poult Sci       Date:  2020-03-20       Impact factor: 3.352

3.  Reverse spillover of avian viral vaccine strains from domesticated poultry to wild birds.

Authors:  M A Rohaim; R F El Naggar; A M Helal; H A Hussein; Muhammad Munir
Journal:  Vaccine       Date:  2017-05-19       Impact factor: 4.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.